Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02386826
Title INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications

glioblastoma

gliosarcoma

Therapies

Bevacizumab + Capmatinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.